This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Synthesis of costs and benefits
Not applicable.
Authors' conclusions
Statistical analysis detected significant effects of both treatments at posttest and follow-up with no between-treatment differences. Analysis of clinically significant change showed superiority of CBT12 at posttest; these differences disappeared at follow-up. Both treatments eliminated the occurrence of panic attacks in 67% of the clients. Assuming that both treatments are equally effective, the authors concluded that CBT4-CA is the more cost-effective treatment.
CRD COMMENTARY -Selection of comparators
A justification for the comparator was given. Multicomponent CBT was the gold standard for treatment of panic disorder.
Validity of estimate of measure of benefit
Because of the small size of the sample, the results need to be treated with some caution.
Validity of estimate of costs
Very few details of the costs of either programme were given, rendering adequate assessment of the validity of estimate of costs difficult. Moreover, the costs were not included as an important element of the analysis.
Other issues

